Feedback / Questions
Byooviz (ranibizumab-nuna) - Samsung, AffaMed Therap, Biogen, Harrow Health
https://www.globenewswire.com/news-release/2026/07/20/3329677/0/en/samsung-bioepis-and-harrow-present-interim-data-from-a-large-scale-post-marketing-surveillance-study-on-sb11-byooviz-amelivu-a-biosimilar-to-lucentis-ranibizumab-at-asrs-2026.html
Jul 20, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next